Sama Atta Gitti, Rayan Zaidan Khalaf, Abdulhadi Alrubaie
{"title":"褪黑素对体重的影响及其作为抗肥胖药物的潜在用途","authors":"Sama Atta Gitti, Rayan Zaidan Khalaf, Abdulhadi Alrubaie","doi":"10.47723/kcmj.v19i2.925","DOIUrl":null,"url":null,"abstract":"Background: obesity is a major global health problem with more than 200 million obese men and almost 300 million obese women. Melatonin is a well-known molecule for its involvement in circadian rhythm regulation and has multiple pathological actions including control of appetite, sleep wake cycle and metabolic syndrome.\nAim: to estimate the effect of melatonin supplements on obese patients on a calorie restricted diet in comparison to patients on lifestyle measures only in the form of weight loss, waist circumference and sleep quality.\nSubjects and Method: one hundred patients with body mass index > 24 were collected, fifty patients were started on melatonin 5 mg with calorie restricted diet and they were compared to fifty patients who were kept on lifestyle measures. After twelve weeks, patients were re-assessed for weight, waist circumference and sleep duration and quality and the development of any side effects. Data analyzed using paired t test.\nResults: patients’ group who were treated with melatonin has shown significant reduction in body weight (91.58. Vs 92.88, p value <0.0004) and waist circumference (99.36 +- 10.73 vs 101 +-10.51, p value< 0.0064). Patients treated with melatonin show improved insomnia severity index (5.47+-0.8 vs 9.08 +-3.58, p value <0.0001). 60% of patients noticed decreased appetite,35% reported daytime sleepiness and fatigue, 25% had dizziness and 20% had mild nausea.\nConclusion: Melatonin significantly reduces the body weight, waist circumference and appetite more than placebo, it has been shown to be safe supplement and helpful in patients with sleep disturbance and obesity.","PeriodicalId":34748,"journal":{"name":"mjlh klyh Tb lkndy","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Effect of Melatonin on Body Weight and the Potential use of Melatonin as an Anti-Obesity Agent\",\"authors\":\"Sama Atta Gitti, Rayan Zaidan Khalaf, Abdulhadi Alrubaie\",\"doi\":\"10.47723/kcmj.v19i2.925\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: obesity is a major global health problem with more than 200 million obese men and almost 300 million obese women. Melatonin is a well-known molecule for its involvement in circadian rhythm regulation and has multiple pathological actions including control of appetite, sleep wake cycle and metabolic syndrome.\\nAim: to estimate the effect of melatonin supplements on obese patients on a calorie restricted diet in comparison to patients on lifestyle measures only in the form of weight loss, waist circumference and sleep quality.\\nSubjects and Method: one hundred patients with body mass index > 24 were collected, fifty patients were started on melatonin 5 mg with calorie restricted diet and they were compared to fifty patients who were kept on lifestyle measures. After twelve weeks, patients were re-assessed for weight, waist circumference and sleep duration and quality and the development of any side effects. Data analyzed using paired t test.\\nResults: patients’ group who were treated with melatonin has shown significant reduction in body weight (91.58. Vs 92.88, p value <0.0004) and waist circumference (99.36 +- 10.73 vs 101 +-10.51, p value< 0.0064). Patients treated with melatonin show improved insomnia severity index (5.47+-0.8 vs 9.08 +-3.58, p value <0.0001). 60% of patients noticed decreased appetite,35% reported daytime sleepiness and fatigue, 25% had dizziness and 20% had mild nausea.\\nConclusion: Melatonin significantly reduces the body weight, waist circumference and appetite more than placebo, it has been shown to be safe supplement and helpful in patients with sleep disturbance and obesity.\",\"PeriodicalId\":34748,\"journal\":{\"name\":\"mjlh klyh Tb lkndy\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-08-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"mjlh klyh Tb lkndy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.47723/kcmj.v19i2.925\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"mjlh klyh Tb lkndy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47723/kcmj.v19i2.925","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
背景:肥胖是一个主要的全球健康问题,有2亿多男性肥胖,近3亿女性肥胖。褪黑素是一种众所周知的参与昼夜节律调节的分子,具有多种病理作用,包括控制食欲、睡眠-觉醒周期和代谢综合征。目的:与仅以减肥、腰围和睡眠质量为形式的生活方式测量的患者相比,评估褪黑素补充剂对热量限制饮食的肥胖患者的影响。受试者和方法:收集100名体重指数>24的患者,50名患者开始服用褪黑激素5mg的热量限制饮食,并与50名保持生活方式的患者进行比较。12周后,对患者的体重、腰围、睡眠时间和质量以及任何副作用的发展进行重新评估。使用配对t检验分析数据。结果:接受褪黑激素治疗的患者组体重显著减轻(91.58。Vs 92.88,p值<0.0004)和腰围(99.36+-10.73 Vs 101+10.51,p值<0.0064)。接受褪黑素治疗的患者失眠严重程度指数有所改善(5.47+-0.8 Vs 9.08+-3.58,p值<0.0001)。60%的患者食欲下降,35%的患者白天嗜睡和疲劳,25%的患者头晕,20%的患者轻度恶心。结论:褪黑素比安慰剂更能显著降低体重、腰围和食欲,是一种安全的补充剂,对睡眠障碍和肥胖患者有帮助。
The Effect of Melatonin on Body Weight and the Potential use of Melatonin as an Anti-Obesity Agent
Background: obesity is a major global health problem with more than 200 million obese men and almost 300 million obese women. Melatonin is a well-known molecule for its involvement in circadian rhythm regulation and has multiple pathological actions including control of appetite, sleep wake cycle and metabolic syndrome.
Aim: to estimate the effect of melatonin supplements on obese patients on a calorie restricted diet in comparison to patients on lifestyle measures only in the form of weight loss, waist circumference and sleep quality.
Subjects and Method: one hundred patients with body mass index > 24 were collected, fifty patients were started on melatonin 5 mg with calorie restricted diet and they were compared to fifty patients who were kept on lifestyle measures. After twelve weeks, patients were re-assessed for weight, waist circumference and sleep duration and quality and the development of any side effects. Data analyzed using paired t test.
Results: patients’ group who were treated with melatonin has shown significant reduction in body weight (91.58. Vs 92.88, p value <0.0004) and waist circumference (99.36 +- 10.73 vs 101 +-10.51, p value< 0.0064). Patients treated with melatonin show improved insomnia severity index (5.47+-0.8 vs 9.08 +-3.58, p value <0.0001). 60% of patients noticed decreased appetite,35% reported daytime sleepiness and fatigue, 25% had dizziness and 20% had mild nausea.
Conclusion: Melatonin significantly reduces the body weight, waist circumference and appetite more than placebo, it has been shown to be safe supplement and helpful in patients with sleep disturbance and obesity.